Anticlastogenic effects of black tea (World blend) and its two active polyphenols theaflavins and thearubigins in vivo in Swiss albino mice.
This study investigated the inhibition of cyclophosphamide (CP) and dimethylbenz(a)anthracene (DMBA) induced genetic damage by black tea (World blend) and its two active polyphenols theaflavins (TF) and thearubigins (TR) in Swiss albino mice as measured by chromosome aberrations (CA) and sister chromatid exchanges (SCE). Three different concentrations (5, 10 and 20%) of tea and a single dose of TF and TR were tested for their anticlastogenic effects against DMBA (50 mg/kg body weight) and CP (20 mg/kg for CA and 10 mg/kg for SCE). A significant decrease in CA was observed in all the three concentrations of tea extract plus DMBA treated groups when compared with the respective DMBA treated group alone. Similarly a significant decrease in CA was observed in all the three concentrations of tea extracts plus CP treated series when compared with the group treated with CP alone. In SCE assay, a significant decrease in SCE was observed in 5, 10 and 20% black tea extract plus CP and 10 and 20% tea extracts plus DMBA treated groups when compared with the CP or DMBA treated group alone. In the single dose of TF and TR treated groups a significant decrease in both CA and SCE was observed in both the TF and TR plus both the carcinogen treated groups when compared with their positive controls. The protective effects of black tea extracts were more significant than that of its two polyphenols. This study indicates that both black tea and its active polyphenols TF and TR have significant anticlastogenic effects in bone marrow cells of mice.
Gupta
S
S
Division of Human Genetics and Genomics, Indian Institute of Chemical Biology, Jadavpur, Calcutta.
Chaudhuri
T
T
Ganguly
D K
DK
Giri
A K
AK
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D044946:Biflavonoids; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D002869:Chromosome Aberrations / Q000187:drug effects*; D003520:Cyclophosphamide / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D008297:Male; D051379:Mice; D009153:Mutagens / Q000633:toxicity; D010636:Phenols / Q000494:pharmacology*; D059808:Polyphenols; D012854:Sister Chromatid Exchange / Q000187:drug effects*; D013662:Tea / Q000737:chemistry*
D016587:Antimutagenic Agents; D044946:Biflavonoids; D009153:Mutagens; D010636:Phenols; D059808:Polyphenols; D013662:Tea; C086701:thearubigin; C056068:theaflavin; D015127:9,10-Dimethyl-1,2-benzanthracene; D003520:Cyclophosphamide; D002392:Catechin